Santen Pharmaceutical Co., Ltd. (SNPHF)
USD 10.53
(0.0%)
USD 10.53
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 43.18 Billion JPY | 9.74% |
| 2023 | 39.35 Billion JPY | 5.95% |
| 2022 | 37.14 Billion JPY | -10.67% |
| 2021 | 41.57 Billion JPY | 17.84% |
| 2020 | 35.28 Billion JPY | 0.13% |
| 2019 | 35.23 Billion JPY | 15.01% |
| 2018 | 30.63 Billion JPY | 7.49% |
| 2017 | 28.5 Billion JPY | 14.03% |
| 2016 | 24.99 Billion JPY | 24.15% |
| 2015 | 20.13 Billion JPY | 0.51% |
| 2014 | 20.03 Billion JPY | -4.38% |
| 2013 | 20.94 Billion JPY | 16.7% |
| 2012 | 17.94 Billion JPY | 22.09% |
| 2011 | 14.7 Billion JPY | 7.93% |
| 2010 | 13.62 Billion JPY | 11.35% |
| 2009 | 12.23 Billion JPY | 7.96% |
| 2008 | 11.33 Billion JPY | 9.41% |
| 2007 | 10.35 Billion JPY | 5.29% |
| 2006 | 9.83 Billion JPY | 0.11% |
| 2005 | 9.82 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 42.22 Billion JPY | 7.31% |
| 2024 Q4 | 43.18 Billion JPY | -7.97% |
| 2024 FY | 43.18 Billion JPY | 9.74% |
| 2024 Q3 | 46.92 Billion JPY | 2.97% |
| 2024 Q2 | 45.56 Billion JPY | 7.91% |
| 2023 Q3 | 37.31 Billion JPY | -4.58% |
| 2023 Q2 | 39.1 Billion JPY | -1.13% |
| 2023 FY | 39.35 Billion JPY | 5.95% |
| 2023 Q4 | 39.35 Billion JPY | 5.47% |
| 2023 Q1 | 39.54 Billion JPY | 6.48% |
| 2022 Q3 | 39.29 Billion JPY | -2.53% |
| 2022 Q1 | 40.67 Billion JPY | -2.17% |
| 2022 Q2 | 40.31 Billion JPY | -0.89% |
| 2022 Q4 | 37.14 Billion JPY | -5.47% |
| 2022 FY | 37.14 Billion JPY | -10.67% |
| 2021 FY | 41.57 Billion JPY | 17.84% |
| 2021 Q1 | 38.66 Billion JPY | 9.58% |
| 2021 Q2 | 40.11 Billion JPY | 3.75% |
| 2021 Q3 | 37.91 Billion JPY | -5.48% |
| 2021 Q4 | 41.57 Billion JPY | 9.66% |
| 2020 Q3 | 33.03 Billion JPY | -1.83% |
| 2020 Q2 | 33.65 Billion JPY | -0.25% |
| 2020 FY | 35.28 Billion JPY | 0.13% |
| 2020 Q1 | 33.73 Billion JPY | -4.25% |
| 2020 Q4 | 35.28 Billion JPY | 6.8% |
| 2019 Q2 | 31.83 Billion JPY | 0.07% |
| 2019 Q4 | 35.23 Billion JPY | 13.36% |
| 2019 Q3 | 31.08 Billion JPY | -2.37% |
| 2019 FY | 35.23 Billion JPY | 15.01% |
| 2019 Q1 | 31.81 Billion JPY | 3.85% |
| 2018 Q2 | 28.06 Billion JPY | 3.81% |
| 2018 FY | 30.63 Billion JPY | 7.49% |
| 2018 Q4 | 30.63 Billion JPY | 11.59% |
| 2018 Q3 | 27.45 Billion JPY | -2.17% |
| 2018 Q1 | 27.03 Billion JPY | -5.16% |
| 2017 Q1 | 25.48 Billion JPY | 1.96% |
| 2017 FY | 28.5 Billion JPY | 14.03% |
| 2017 Q4 | 28.5 Billion JPY | 8.77% |
| 2017 Q3 | 26.2 Billion JPY | -2.16% |
| 2017 Q2 | 26.78 Billion JPY | 5.09% |
| 2016 Q2 | 22.01 Billion JPY | 0.1% |
| 2016 Q1 | 21.98 Billion JPY | 9.21% |
| 2016 FY | 24.99 Billion JPY | 24.15% |
| 2016 Q4 | 24.99 Billion JPY | 11.08% |
| 2016 Q3 | 22.5 Billion JPY | 2.24% |
| 2015 Q3 | 18.33 Billion JPY | -1.67% |
| 2015 Q4 | 20.13 Billion JPY | 9.79% |
| 2015 FY | 20.13 Billion JPY | 0.51% |
| 2015 Q1 | 24.18 Billion JPY | 20.72% |
| 2015 Q2 | 18.65 Billion JPY | -22.87% |
| 2014 FY | 20.03 Billion JPY | -4.38% |
| 2014 Q4 | 20.03 Billion JPY | 9.57% |
| 2014 Q3 | 18.28 Billion JPY | -8.14% |
| 2014 Q2 | 19.9 Billion JPY | -2.36% |
| 2014 Q1 | 20.38 Billion JPY | -2.7% |
| 2013 FY | 20.94 Billion JPY | 16.7% |
| 2013 Q4 | 20.94 Billion JPY | 16.89% |
| 2013 Q2 | 17.26 Billion JPY | 2.76% |
| 2013 Q3 | 17.92 Billion JPY | 3.78% |
| 2013 Q1 | 16.8 Billion JPY | -6.37% |
| 2012 Q4 | 17.94 Billion JPY | 26.15% |
| 2012 Q3 | 14.22 Billion JPY | -7.73% |
| 2012 Q2 | 15.42 Billion JPY | -1.85% |
| 2012 Q1 | 15.71 Billion JPY | 6.86% |
| 2012 FY | 17.94 Billion JPY | 22.09% |
| 2011 Q3 | 13.29 Billion JPY | -0.45% |
| 2011 FY | 14.7 Billion JPY | 7.93% |
| 2011 Q1 | 13.7 Billion JPY | 0.62% |
| 2011 Q2 | 13.35 Billion JPY | -2.58% |
| 2011 Q4 | 14.7 Billion JPY | 10.59% |
| 2010 Q3 | 11.87 Billion JPY | -4.34% |
| 2010 FY | 13.62 Billion JPY | 11.35% |
| 2010 Q2 | 12.41 Billion JPY | 0.0% |
| 2010 Q4 | 13.62 Billion JPY | 14.74% |
| 2009 Q4 | 12.23 Billion JPY | 0.0% |
| 2009 FY | 12.23 Billion JPY | 7.96% |
| 2008 FY | 11.33 Billion JPY | 9.41% |
| 2007 FY | 10.35 Billion JPY | 5.29% |
| 2006 FY | 9.83 Billion JPY | 0.11% |
| 2005 FY | 9.82 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AstraZeneca PLC | 5.41 Billion USD | -697.309% |
| Bristol-Myers Squibb Company PFD CONV 2 | 2.66 Billion USD | -1522.276% |
| CSPC Pharmaceutical Group Limited | 442.43 Million USD | -9660.834% |
| Clarus Therapeutics Holdings, Inc. | 14.21 Million USD | -303720.177% |
| Novartis AG | 5.91 Billion USD | -630.34% |
| PT Kalbe Farma Tbk. | 451.27 Million USD | -9469.449% |